About BSAC

Founded in 1971, and with over 5,000 members in 135 countries around the world, the British Society for Antimicrobial Chemotherapy (BSAC) is a global educator, joining the dots between scientific researchers, medical communities and the wider public, encouraging and enabling them to pass on their knowledge to a global audience.

Our internationally renowned publications are among the foremost international journals in antimicrobial research, while our commitment to scientific excellence is reflected in our varied programme of events, training and free educational resources.

We know that better education can help prevent disease, develop more effective practice and influence international policy. Working together, we can ensure a safer world by developing new drugs, while making sure the ones we already have are used responsibly and protected for future generations.

Council

Officers

Professor Andrew Seaton

President

Dr Alicia Demirjian

Vice President

Dr Mike Allen

General Secretary

Dr Chris Longshaw

Honorary Treasurer

Dr Michelle Buckner

Academic Affairs

Ms Sally Tipping

Education Secretary

Dr Matthew Dryden

International Affairs

Ordinary Members

Dr Ioannis Baltas
Dr Miruna David
Dr Jane Democratis
Mr Kenneth Egwu
Dr Rasha Elshenawy
Dr Aoife Fleming
Dr Annie Joseph
Professor Paul Long
Dr Helena Parsons
Dr Louise Sweeney
Dr Liz Tayler

Co-opted Members

Professor Pete Borriello
Dr Nick Brown
Professor Mark Gilchrist
Dr Gail Hayward
Professor Philip Howard
Dr Sanjay Patel
Dr Wendy Thompson

Governance

Memorandum and Articles of Association (MAA) is the statutory instrument that governs the operation of the BSAC. The MAA can only be amended with the approval of the Charity Commission.

The Regulations, that can be amended by Council, further define the MAA and establish operational procedures for BSAC business.

The Register of Interests offers provisions for members, throughout the submission of transparency declarations and voluntary or requested withdrawal from meetings, to ensure that they are not influenced, or appearing to be influenced, by their private interests in the execution of their duties on behalf of the Society. The BSAC Register of Interests is regularly updated and a copy can be provided on receipt of a written request to the Chief Executive Officer.

Copies of the all governance documents can be requested from the BSAC Office.

Memorandum and Articles of Association Download
Regulations Download
UK Expenses Claim Form 2020 Download
Principles for expenditure Download

Registered Charity 1093118
Registered as a company limited by guarantee in England & Wales No: 4443910

Strategy 2025 to 2028

Our mission is to build the world’s most dynamic community of infection experts

Our vision is a world where the healthcare workforce is equipped to prevent and manage infection including those due to drug-resistant pathogens

We fulfil the mission, and work towards the vision, through a set of strategic aims and core values

Our strategic aims

  1. Advancing knowledge and understanding Expanding world-class education, training, and knowledge-dissemination to embed evidence-led practices related to responsible and sustainable antimicrobial development, manufacture, distribution, and use – while ensuring equitable access across all regions
  2. Developing policy and advocacy Informing and influencing local, national, and global policies, holding decision-makers to account, advocating for sustainable antimicrobial use, and championing equitable access to appropriate treatments
  3. Fostering innovation and collaboration Connecting networks—across academia, industry, and healthcare—to drive innovative solutions for infection prevention, diagnosis, and treatment
  4. Developing standards and best practice Leading the development of standards, providing assurance mechanisms, and promoting best practice in antimicrobial stewardship, infection management, and diagnostics to improve patient outcomes and public health
  5. Empowering the global community of practice Acting as a trusted adviser, facilitator, and thought-leader to concentrate expertise, guidance, and support, in a way that can be accessed by all professionals involved in the infection patient pathway, from prevention to treatment.

Our core values

  1. Leadership and independence We lead with authority and integrity, using an impartial voice that speaks according to evidence
  2. People-centred We focus on improving patient outcomes and protecting public health through the wider “one health” approach
  3. Collaboration and inclusivity We unite a wide range of stakeholders, ensuring all voices are heard and considered
  4. Innovation and agility We embrace change, take positive risks, and respond to threats and opportunities in a timely way
  5. Impact and accountability We hold ourselves and others to the highest ethical and scientific standards, while endeavouring to evaluate the difference we and others make through our activities.

Secretariat

Michael Corley

Chief Executive Officer

Tracey Guise

Deputy Chief Executive Officer

Liam Brown

Head of Communication

Esme Carruthers

Head of Education and Events Manager

Charlotte McNeill

Finance, Facilities and Human Resources

Sarah Esberger

Publications Officer

Ryan Hamilton

GAMSAS Programmes Lead

Spela Oberstar

Projects Lead

Neil Watson

Digital Development & Design Lead

Fran Garraghan

Programme Lead

Rhian Foley

Public Affairs Lead

Claire Oxlade

Membership and Global Engagement Lead

Contact us

BSAC Office

Tel: +44 (0)121 236 1988

Address

British Society for Antimicrobial Chemotherapy
53 Regent Place
Birmingham
B1 3NJ

Email enquiries

Membership@bsac.org.uk